INSM — Insmed Incorporated Share News
0.000.00%
Last trade - 00:00- $21.67bn
- $21.23bn
- $606.42m
U.S. RESEARCH ROUNDUP-Home Depot, News, Premier
U.S. RESEARCH ROUNDUP-U.S. RESEARCH ROUNDUP: Air Products, Biogen and JLL
Street View: FDA nod for Insmed's lung disease drug is 'breath of fresh air'
U.S. RESEARCH ROUNDUP-Apollo, Blackstone, Nvidia
Brief: FDA Approves Brinsupri As First Treatment For Non-Cystic Fibrosis Bronchiectasis
US FDA approves Insmed's lung disease drug (updated)
Refile: US FDA approves Insmed's lung disease drug
U.S. RESEARCH ROUNDUP-Bd, Caci International, Caterpillar
Insmed Inc reports results for the quarter ended June 30 - Earnings Summary
Biopharma Insmed's Q2 revenue up 19%, beats estimates
U.S. STOCKS ON THE MOVE-Moderna, Cardinal Health, Adobe
U.S. STOCKS ON THE MOVE-CureVac, Conagra, Oklo
U.S. STOCKS ON THE MOVE-Esty, America's Car-Mart, ImmunoPrecise
Insmed dips after $750 mln stock sale
Brief: Insmed Announces Pricing Of $750 Million Public Offering Of Common Stock At $96 Per Share
Insmed dips on planned $650 mln stock sale
U.S. RESEARCH ROUNDUP- Caseys General Stores, Illumina, Starbucks
Insmed hits more than two-decade high as rare lung disease drug succeeds in trial
U.S. STOCKS ON THE MOVE-Citigroup, Boeing, Calavo Growers